Viewing Study NCT04536792


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2025-12-24 @ 3:51 PM
Study NCT ID: NCT04536792
Status: COMPLETED
Last Update Posted: 2024-04-16
First Post: 2020-07-15
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease
Sponsor: Agios Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-07-10
Start Date Type: ACTUAL
Primary Completion Date: 2023-12-19
Primary Completion Date Type: ACTUAL
Completion Date: 2023-12-19
Completion Date Type: ACTUAL
First Submit Date: 2020-07-15
First Submit QC Date: None
Study First Post Date: 2020-09-03
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-04-15
Last Update Post Date: 2024-04-16
Last Update Post Date Type: ACTUAL